American Pharmaceutical Partners to Present at The Bear Stearns 18th Annual Healthcare Conference on September 12
- Live Webcast Accessible at www.appdrugs.com -
SCHAUMBURG, Ill., Sept. 6 /PRNewswire-FirstCall/ -- American
Pharmaceutical Partners, Inc. (Nasdaq: APPX) today said that the company's
senior management will present a company overview at the Bear Stearns 18th
Annual Healthcare Conference on Monday, September 12, 2005 at 3:30 p.m.
Eastern at the Grand Hyatt Hotel in New York.
The presentation will be available to interested parties through a live
webcast at APP's Web site, http://www.appdrugs.com. Listeners are encouraged
to visit the Web site at least 15 minutes prior to the beginning of the
scheduled presentation to register, download and install any necessary audio
software. For those unable to listen to the live webcast, the presentation
will be archived on the same Web site for approximately one month.
About American Pharmaceutical Partners
American Pharmaceutical Partners, Inc. is a specialty drug company that
develops, manufactures and markets injectable pharmaceutical products,
focusing on the oncology, anti-infective and critical care markets. Abraxis
Oncology, the proprietary division of APP, is devoted entirely to developing
and promoting innovative, next-generation cancer therapies such as
ABRAXANE(TM), recently launched for the treatment of metastatic breast cancer.
For more information, visit APP's website at http://www.appdrugs.com and
Contacts: American Pharmaceutical Partners, Inc.
Executive Vice President & CFO
Robert Jaffe/Rob Whetstone
SOURCE American Pharmaceutical Partners, Inc.
4463 09/06/2005 07:12 EDT http://www.prnewswire.com